SAN FRANCISCO--(BUSINESS WIRE)--Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, today announced the first patient enrollment in ...

SANTA BARBARA, Calif., April 10, 2025 /PRNewswire/ -- Artera, a SaaS digital health leader trusted by more than 900 healthcare organizations and federal agencies, today announced the continued ...

Healthcare staff members are finding Artera’s AI copilots helpful and easy to use after six months of real-world deployment. Artera, a digital health software company based in Santa Barbara ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more than 50% of all oncologists practising in the US, Chicago-based Tempus ...